Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?
Authors:
- S N CaroffSCS N Caroff
- S L McElroySMS L McElroy
- 1 May 1995
- journal article
- review article
- Published by American Psychiatric Association Publishing in The Journal of Neuropsychiatry and Clinical Neurosciences
- Vol. 7 (2) , 135-144
Abstract
Two primary hypotheses have been proposed to explain the pathophysiology of the neuroleptic malignant syndrome (NMS): 1) that NMS is produced by abrupt and extensive central dopamine receptor blockade by neuroleptics, particularly in nigrostriatal and hypothalamic pathways; and 2) that NMS, like malignant hyperthermia (MH), results from a preexisting defect in skeletal muscle metabolism that is unmasked or provoked by neuroleptic exposure. To evaluate these models, the authors review studies published since 1980 of the clinical features, epidemiology, risk factors, laboratory assessment, and relevant animal models of NMS and MH. Data from these studies suggest that although NMS and MH are clinically similar, they are pharmacologically distinct, implying that cross-reactivity between triggering agents is unlikely to occur.Keywords
This publication has 70 references indexed in Scilit:
- A case of neuroleptic malignant syndrome with a history of general anesthesiaHuman Psychopharmacology: Clinical and Experimental, 1992
- Risk Factors for Neuroleptic Malignant SyndromeArchives of General Psychiatry, 1989
- Stereoselective analysis of racemic psychotropic compounds by HPLC on chiral stationary phasePsychopharmacology, 1986
- Markedly Delayed Postoperative Malignant HyperthermiaJAMA Otolaryngology–Head & Neck Surgery, 1986
- Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermiaMuscle & Nerve, 1985
- The genetics of malignant hyperthermia: Evidence for heterogeneityAmerican Journal of Medical Genetics, 1982
- Hormonal hyperthermiaThe American Journal of Medicine, 1979
- Rigidity, hyperpyrexia and coma following fluphenazine enanthatePsychopharmacology, 1973
- Muscle Enzyme Release in the Acute PsychosesArchives of General Psychiatry, 1969
- Beeinflussung des Calcium-Austauschs und der Muskelfunktion des M. rectus und sartorius des Frosches durch Chlorpromazin, Prenylamin, Imipramin und ReserpinNaunyn-Schmiedeberg's Archives of Pharmacology, 1969